Judith Boice, PhD

Tremeau Pharmaceuticals, Inc
Concord, MA, United States

Chief development officer with extensive experience in the pharmaceutical industry in drug development including drugs indicated in rheumatology, immunology and painful conditions.

Disclosure information not submitted.

Presentation(s):

• 1751: Diagnosing the Cardiovascular Risk of VIOXX: A Place for Rofecoxib in Pain Management

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• 1831: Establishing a Scientific Bridge to Historic VIOXX to Enable a Reintroduction of Rofecoxib: Pharmacokinetic Evaluation of TRM‑201 (Rofecoxib)

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time